Therapeutic Potential of Luteolin for Diabetes Mellitus and Its Complications.
10.1007/s11655-024-3917-z
- Author:
Xiao-Qin CHANG
1
;
Ren-Song YUE
2
Author Information
1. Endocrinology Department, Affiliated Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, 610075, China.
2. Endocrinology Department, Affiliated Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, 610075, China. 1580229694@qq.com.
- Publication Type:Review
- Keywords:
complication;
diabetes mellitus;
endothelial dysfunction;
inflammation;
luteolin;
neuroprotection;
oxidative stress
- MeSH:
Humans;
Luteolin/pharmacology*;
Diabetes Mellitus/drug therapy*;
Diabetes Complications/drug therapy*;
Animals;
Antioxidants/therapeutic use*
- From:
Chinese journal of integrative medicine
2025;31(6):566-576
- CountryChina
- Language:English
-
Abstract:
The global prevalence of diabetes mellitus (DM) and its complications has been showing an upward trend in the past few decades, posing an increased economic burden to society and a serious threat to human life and health. Therefore, it is urgent to investigate the effectiveness of complementary and alternative therapies for DM and its complications. Luteolin is a kind of polyphenol flavonoid with widely existence in some natural resources, as a safe dietary supplement, it has been widely studied and reported in the treatment of DM and its complications. This review demonstrates the therapeutic potential of luteolin in DM and its complications, and elucidates the action mode of luteolin at the molecular level. It is characterized by anti-inflammatory, antioxidant, and neuroprotective effects. In detail, luteolin can not only improve endothelial function, insulin resistance and β-cell dysfunction, but also inhibit the activities of dipeptidyl peptidase-4 and α-glucosidase. However, due to the low water solubility and oral bioavailability of luteolin, its application in the medical field is limited. Therefore, great importance should be attached to the joint application of luteolin with current advanced science and technology. And more high-quality human clinical studies are needed to clarify the effects of luteolin on DM patients.
